STERIS plc STE 80.34
Health Care · NYSE · Data as of 2026-08-07
STERIS plc (STE) has delivered +10.9% annualized revenue growth, +12.5% earnings growth, and +11.7% dividend growth over 10 years of data. Ranked #100 of 1968 stocks overall and #10 of 260 in the Health Care sector by Steady Score.
About STERIS plc
Company Overview
STERIS provides products and services that help healthcare and life-sciences customers prevent infection and maintain sterile environments. Its portfolio includes sterilizers, washers, surgical tables, endoscope-processing equipment, consumables and maintenance. The company also provides outsourced sterilization and laboratory services for medical- device and pharmaceutical manufacturers and contamination-control products for research and production facilities worldwide. Its offerings support procedures and manufacturing processes where consistent sterility and documentation are essential.
Read more
Business Model & Revenue
Revenue comes from capital equipment, recurring consumables, service contracts and outsourced sterilization. An installed base in hospitals generates demand for maintenance and proprietary consumables, while Applied Sterilization Technologies processes customer products under long-term relationships at specialized facilities. Life Sciences supplies cleanroom and bioprocess customers. Procedure volumes, device production, capacity utilization, new equipment cycles, regulation and overall facility reliability drive performance.
Key Facts & Market Position
STERIS reports Healthcare, Applied Sterilization Technologies and Life Sciences segments. Its activities are embedded in regulated infection-prevention and product-release workflows, creating high requirements for quality and continuity. Recurring consumables, service and outsourced processing balance equipment sales, while capacity expansion, regulatory compliance, customer concentration and uninterrupted operation of sterilization facilities are important.